Open AccessEvery-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomized multicenter study (INCOMIN).
Author(s) -
Thomas R. Mizen
Publication year - 2003
Publication title -
journal of neuro-ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.586
H-Index - 55
eISSN - 1536-5166
pISSN - 1070-8022
DOI - 10.1097/00041327-200303000-00046
Subject(s) - multiple sclerosis , interferon beta 1b , medicine , interferon beta 1a , interferon beta , interferon , randomized controlled trial , prospective cohort study , multicenter study , multicenter trial , gastroenterology , immunology